Journal of Clinical Investigation 2015-03-02

Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.

Xiaorong Zhu, Jeannette S Messer, Yunwei Wang, Fanfei Lin, Candace M Cham, Jonathan Chang, Timothy R Billiar, Michael T Lotze, David L Boone, Eugene B Chang

文献索引：J. Clin. Invest. 125(3) , 1098-110, (2015)

全文：HTML全文

摘要

The intracellular protein HMGB1 is released from cells and acts as a damage-associated molecular pattern molecule during many diseases, including inflammatory bowel disease (IBD); however, the intracellular function of HMGB1 during inflammation is poorly understood. Here, we demonstrated that cytosolic HMGB1 regulates apoptosis by protecting the autophagy proteins beclin 1 and ATG5 from calpain-mediated cleavage during inflammation. Colitis in mice with an intestinal epithelial cell-specific Hmgb1 deletion and patients with IBD were both characterized by increased calpain activation, beclin 1 and ATG5 cleavage, and intestinal epithelial cell (IEC) death compared with controls. In vitro cleavage assays and studies of enteroids verified that HMGB1 protects beclin 1 and ATG5 from calpain-mediated cleavage events that generate proapoptotic protein fragments. Together, our results indicate that HMGB1 is essential for mitigating the extent and severity of inflammation-associated cellular injury by controlling the switch between the proautophagic and proapoptotic functions of beclin 1 and ATG5 during inflammation. Moreover, these studies demonstrate that HMGB1 is pivotal for reducing tissue injury in IBD and other complex inflammatory disorders.